Hepatitis & cancer screening push: Macau’s Health Bureau (SSM) is expanding early detection with more hepatitis testing and cancer screening under the “Healthy Macao Action Plan,” including hepatitis B screening for residents over 40 with no prior record; by end-2025, over 19,000 people were screened and more than 1,300 confirmed cases were found, with future invitations planned via the Macao One Account. Macao’s health-linked development roadmap: The SAR’s Third Five-Year Plan (2026–2030) puts people well-being at the center, aiming to strengthen public services such as healthcare, elderly support and social security while accelerating economic diversification and closer integration with Hengqin. Exercise for heart protection (study): A new study in the British Journal of Sports Medicine suggests heart-attack and stroke risk drops meaningfully only with much more weekly moderate-to-vigorous activity than standard guidance—about 560 to 610 minutes per week. New ophthalmic drug approval abroad: Kanghong’s conbercept ophthalmic injection (Lumitin) received marketing authorization in Guyana, adding another overseas regulatory milestone for the anti-VEGF biologic used for retinal diseases. Work safety in extreme heat: A lawmaker urges clearer rules for outdoor workers during extreme weather, including limits on working hours and better rest-period guidance to reduce heatstroke risk. Clinical trial update (vision care): EyePoint reported topline data from LUGANO, the first of two Phase 3 trials for DURAVYU™ 2.7mg in wet AMD.